Related Experiment Videos
The comparative pathobiology of atherosclerosis and restenosis
J L Orford1, A P Selwyn, P Ganz
1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Insights
Percutaneous coronary interventions (PCIs) can lead to restenosis. Understanding the distinct pathobiology of atherosclerosis and restenosis is crucial for developing effective treatment plans for coronary artery disease patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Pathobiology
Background:
- Percutaneous coronary interventions (PCIs) are vital for managing coronary artery disease.
- Restenosis complicates a significant number of PCIs.
- Atherosclerosis involves complex interactions of lipids, endothelium, inflammatory cells, platelets, and vascular smooth muscle cells.
Purpose of the Study:
- To review and contrast the pathobiology of atherosclerosis and restenosis.
- To compare the mechanisms and time-course of these distinct entities.
- To provide a rational basis for treatment plans addressing both atherosclerosis and restenosis.
Main Methods:
- Review of existing literature on atherosclerosis and restenosis pathobiology.
- Comparative analysis of the mechanisms and temporal progression of both conditions.
- Synthesis of pathobiological differences to inform clinical strategy.
Main Results:
- PCI superimposes mechanical and cellular consequences on the atherosclerotic substrate.
- This interaction leads to a distinct pathobiology that initiates and perpetuates restenosis.
- Significant differences exist between the pathobiology of atherosclerosis and restenosis.
Conclusions:
- Differentiating atherosclerosis and restenosis pathobiology is essential for effective patient management.
- Targeting both underlying atherosclerosis and the restenosis process is necessary.
- A clear understanding informs the development of comprehensive treatment strategies for coronary artery disease.
Abstract:
Percutaneous coronary interventions (PCIs) play an increasingly important role in the management of patients with coronary artery disease. However, these important procedures are complicated by restenosis in a sizeable number of patients. The pathobiology of atherosclerosis comprises a complex interaction among lipids, the endothelium, circulating and tissue inflammatory cells, platelets, and vascular smooth muscle cells. The superimposition of the mechanical and cellular consequences of PCIs on the abnormal substrate of atherosclerosis leads to a characteristic and distinct pathobiology that initiates and perpetuates restenosis. A clear understanding of the significant differences between atherosclerosis and restenosis will provide a rational basis for developing treatment plans that always address both problems. This article reviews and contrasts the pathobiology of atherosclerosis and restenosis and compares the mechanisms and time-course of these distinct entities.